Hehlmann R, Lauseker M, Saussele S. et al. Final Evaluation of Randomized CML-Study IV: 10-Year Survival and Evolution of Terminal Phase. ASH 59th Annual Meeting & Exhibition, abstract 897.
Pomalidomide, bortezomib en dexamethason effectief bij lenalidomide-refractair recidief MM
jul 2017 | MM